| Dr Tina Concetta Zecca, DO | |
|
200 White Rd, Ste 205, Little Silver, NJ 07739-1150 | |
| (732) 741-8222 | |
| (732) 741-6217 |
| Full Name | Dr Tina Concetta Zecca |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 33 Years |
| Location | 200 White Rd, Little Silver, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790753630 | NPI | - | NPPES |
| 40573 | Other | NJ | AMERIGROUP |
| P1112646 | Other | NJ | OXFORD |
| P00361726 | Other | NJ | RR MEDICARE |
| 0128757 | Other | NJ | GHI |
| 5N9742 | Other | NJ | BLUE CROSS |
| 3K4214 | Other | NJ | HEALTHNET |
| ES000043503 | Other | NJ | AMERICHOICE |
| 5472073 | Other | NJ | AETNA PPO |
| 8607403 | Other | NJ | CIGNA |
| 0712593000 | Other | NJ | AMERIHEALTH |
| 1163900 | Other | NJ | HORIZON NJ HEALTH |
| 1380878 | Other | NJ | AETNA HMO |
| 7584709 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MB58459 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverview Medical Center | Red bank, NJ | Hospital |
| Entity Name | Allergy & Asthma Associates Of Monmouth County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790830537 PECOS PAC ID: 8224130505 Enrollment ID: O20070219000029 |
News Archive
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
A new study led by University of North Carolina School of Medicine researchers is the first to identify a genetic risk factor for persistent pain after traumatic events such as motor vehicle collision and sexual assault.
OPKO Health, Inc., has completed patient recruitment in the first phase 3 trial of Rayaldy to treat patients with secondary hyperparathyroidism, stage 3 or 4 chronic kidney disease and vitamin D insufficiency.
In a message marking Monday's World Malaria Day, Luis Gomes Sambo, WHO's regional director for Africa, noted that this year signifies the end of the U.N. decade to roll back malaria and "offers an opportunity for renewed commitment" to fight the disease, the Angola Press reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tina Concetta Zecca, DO 200 White Rd, Suite 205, Little Silver, NJ 07739-1150 Ph: (732) 741-8222 | Dr Tina Concetta Zecca, DO 200 White Rd, Ste 205, Little Silver, NJ 07739-1150 Ph: (732) 741-8222 |
News Archive
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
A new study led by University of North Carolina School of Medicine researchers is the first to identify a genetic risk factor for persistent pain after traumatic events such as motor vehicle collision and sexual assault.
OPKO Health, Inc., has completed patient recruitment in the first phase 3 trial of Rayaldy to treat patients with secondary hyperparathyroidism, stage 3 or 4 chronic kidney disease and vitamin D insufficiency.
In a message marking Monday's World Malaria Day, Luis Gomes Sambo, WHO's regional director for Africa, noted that this year signifies the end of the U.N. decade to roll back malaria and "offers an opportunity for renewed commitment" to fight the disease, the Angola Press reports.
› Verified 3 days ago
Dr. Feryal Hajee, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 34 Sycamore Ave Ste 1a, Little Silver, NJ 07739 Phone: 732-383-5554 Fax: 732-383-5495 |